2seventy bio Inc. - רווח נקי למניה ב-12 החודשים האחרונים TSVT

2seventy bio, Inc. (TSVT) masterfully integrates complex genetic developments into real-world medical practice. This chart of rolling annual EPS growth demonstrates the pace of business recovery, where the value of 59.10 serves as the current metric. The issuer is increasing Abecma sales in a drive toward profitability. The strategy relies on the monetization of its core product and revenue sharing with its partner following the sale of R&D assets.

The performance dynamics of 2seventy bio, Inc. (TSVT) are reflected in the 12-month YoY EPS trend. This indicator captures the annual growth rate of earnings per share, neutralizing time lags between quarterly reports. The calculation is based on a rolling comparison of the current TTM figure against the same period last year. Production stability via CMO partners directly impacts this metric, determining operating profitability. Analyzing this chart prevents the purchase of overvalued assets.